Bradley J. Bolzon Ph.D., Director, 10% Owner at Black Diamond Therapeutics, Inc. (BDTX), sold 33,306 shares at $34.39 ($991K) on 2020-11-12, disclosed to the SEC on 2020-11-13.
Open-market sale of $991k BDTX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 4,282 | $0 | 0.0% |
| 2 | $33.48 | 3,976 | $133K | 13.4% |
| 3 | $33.48 | 3,976 | $133K | 13.4% |
| 4 | $33.48 | 524 | $18K | 1.8% |
| 5 | $34.39 | 9,450 | $325K | 32.8% |
| 6 | $34.39 | 1,248 |
| $43K |
| 4.3% |
| 7 | $34.39 | 9,450 | $325K | 32.8% |
| 8 | $35.15 | 47 | $2K | 0.2% |
| 9 | $35.15 | 353 | $12K | 1.3% |
| Total | $29.75 avg | 33,306 | $991K | 100% |
| Filing → |
| CRSP | SELL | 2021-06-30 | $14.1M | — | Filing → |
| CRSP | SELL | 2021-06-30 | $9.2M | — | Filing → |
| CRSP | SELL | 2021-06-15 | $2.3M | — | Filing → |